Elimination half-life of intravenously administered equine cardiac troponin I in healthy ponies.

Summary

# Editorial Summary Cardiac troponin I (cTnI) is increasingly used to detect myocardial injury in horses, yet the kinetics governing its clearance from circulation remained unknown—a significant knowledge gap when interpreting troponin results in acute cases. Researchers administered intravenous recombinant equine cTnI to four healthy ponies and tracked plasma concentrations using point-of-care analysers at sequential time intervals, applying standard pharmacokinetic modelling to determine the elimination half-life. The results revealed remarkably rapid clearance, with cTnI demonstrating a half-life of just 0.47 hours (approximately 28 minutes). This extremely short elimination window has important clinical implications: troponin samples must be obtained soon after suspected myocardial injury to avoid false-negative results, and serial sampling protocols may be necessary to capture peak concentrations and confirm acute events rather than chronic damage. For practitioners investigating horses with acute cardiac concerns, this finding underscores the critical importance of timing blood collection relative to the clinical incident, and supports the use of troponin as a sensitive marker of recent rather than historical myocardial compromise.

Read the full abstract on PubMed

Key Findings

• •Elimination half-life of equine cardiac troponin I is 0.47 hours following intravenous administration
• •cTnI is rapidly eliminated from plasma in healthy ponies using single rate elimination model
• •Recombinant equine cTnI shows very rapid clearance kinetics

Conditions Studied